Every earnings call for ONESOURCE — management tone, guidance, KPIs and promise tracking, quarter by quarter.
ONESOURCE · 5 transcripts · Healthcare · latest Q4 FY26Revenue 4282 million; EBITDA 919 million; Adjusted PAT 390 million. Q4 FY26 revenue at INR 4,282 million, up 47% sequentially.
Read full transcript & analysisRevenue 2903 million (−26% YoY); EBITDA 173 million; Adjusted PAT -472 million. Revenue reported at ₹2,903 million, representing a 26% YoY decline due to semaglutide approval delays in Canada.
Read full transcript & analysisRevenue ₹327 cr (+12% YoY); EBITDA ₹88 cr (+37% YoY); EBITDA Margin 27%. Revenue reported at ₹327.3 crores, representing a 12% YoY growth.
Read full transcript & analysisRevenue 14449 million (+30% YoY); Operating EBITDA 4665 million (+100% YoY); EBITDA Margin 43%. Full year FY25 revenue exceeded ₹1,445 crores, representing 30% YoY growth.
Read full transcript & analysisRevenue ₹393 cr (+18% YoY); EBITDA ₹143 cr; EBITDA Margin 36.0%. Revenue for Q3 FY25 stood at ₹392.6 crores, representing approximately 18% growth.
Read full transcript & analysis